January 2015

  • Greek elections: anger overcame fear, but is there hope?

    Now that Syriza has formed a government which has already made some statements on its legislative agenda, there is now a little more clarity on  the road forward, and it’s of little comfort to many across Europe and in the troika. Tsipras has just criticised the EU for its stance on Russia, has put the…

  • United by austerity

    By George Candon, Orestis Kalliantzidis and Constantine Levoyannis The dust had barely settled on the outcome of the much-anticipated Greek general election which saw Syriza fall just two tantalizing seats short of an outright majority*, when hot on the heals comes the news that the hard-left party has jumped into bed with the populist rightwing…

  • Greek elections: Fear. Anger. Hope?

    Left-wing Syriza is primed to win power in next Sunday’s general elections in Greece, causing something of a political earthquake not just within Greece, but also without. Syriza has been vocal in talking up renegotiating Greece’s bailout terms and significantly increasing public spending to help those worst hit by austerity measures. Will this mean a…

  • HTA cooperation at EU level: From “agreeing on to doing”, from therapeutic added value to cost effectiveness

    The heated debate over price transparency before the Christmas break distracted us from another important development which, being often perceived as too technical and theoretical, may in fact result in significant changes for the pharmaceutical industry: EU level cooperation on Health Technology Assessments (HTA) – the method for assessing the ways science & technology are…

  • Can high-priced medicines constitute an abuse of a dominant position in the EU?

    The price of medicines has inevitably always been, and is likely to remain, a long-standing matter of contention between originator companies, governments and patients. It has however become more acute since the launch of some very innovative but very highly priced medicines in recent months, says FTI Consulting’s Darren Kinsella.   Never mind that these…

Back to top